These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 8849291

  • 1. [Clinical study of ambulatory cancer chemotherapy for advanced colorectal cancer].
    Takahashi N, Kunii Y, Ota K.
    Gan To Kagaku Ryoho; 1995 Dec; 22 Suppl 4():447-52. PubMed ID: 8849291
    [Abstract] [Full Text] [Related]

  • 2. [Clinical study of ambulatory patient cancer chemotherapy for advanced colorectal cancer].
    Toyokawa A, Tsujimura T, Hamabe Y, Sato S, Mukubou H, Wakahara T, Kaji M, Tsukamoto T, Wakita K, Onishi N, Ishida T, Watanabe A, Fujiwara H, Mukai H.
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2087-90. PubMed ID: 16352933
    [Abstract] [Full Text] [Related]

  • 3. [Clinical study of ambulatory cancer chemotherapy for recurrent breast cancer].
    Takahashi N, Nitta A, Kunii Y, Ota K.
    Gan To Kagaku Ryoho; 1994 Dec; 21 Suppl 4():439-43; discussion 443-4. PubMed ID: 7802447
    [Abstract] [Full Text] [Related]

  • 4. Activity of high dose 24 hour 5-fluorouracil infusion plus L-leucovorin in advanced colorectal cancer.
    Nobile MT, Barzacch MC, Sanguineti O, Chiara S, Gozza A, Vincenti M, Lavarello A, Cognein P, Lionetto R, Percivale PL, Bertoglio S, Murolo C, Esposito M, Vannozzi MO, Rosso R.
    Anticancer Res; 1998 Dec; 18(1B):517-21. PubMed ID: 9568171
    [Abstract] [Full Text] [Related]

  • 5. [Early phase II trial of l-leucovorin and 5-fluorouracil in advanced colorectal cancer. l-Leucovorin and 5-FU Study Group].
    Sugano K, Ota K, Taguchi T, Ogawa N, Kurihara M, Akazawa S, Ogawa M, Tominaga T, Sasaki T, Konishi T.
    Gan To Kagaku Ryoho; 1995 Apr; 22(5):627-37. PubMed ID: 7717714
    [Abstract] [Full Text] [Related]

  • 6. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I, Jelić S, Radosavljević D, Nikolić-Tomasević A.
    Srp Arh Celok Lek; 1998 Apr; 126(9-10):355-61. PubMed ID: 9863407
    [Abstract] [Full Text] [Related]

  • 7. Double modulation of 5-fluorouracil by leucovorin and low-dose methotrexate in advanced colorectal cancer.
    Stabuc B, Markovic A, Plesnicar A, Cizej TE.
    Neoplasma; 2000 Apr; 47(4):248-52. PubMed ID: 11043831
    [Abstract] [Full Text] [Related]

  • 8. [A late phase II trial of l-leucovorin and 5-fluorouracil in advanced colorectal cancer. l-Leucovorin and 5-FU Study Group (Japan Western Group)].
    Konishi K, Yabushita K, Taguchi T, Ota J, Takashima S, Abe T, Kikkawa N, Yasutomi M, Sowa M, Maehara Y.
    Gan To Kagaku Ryoho; 1995 Jun; 22(7):925-32. PubMed ID: 7793998
    [Abstract] [Full Text] [Related]

  • 9. Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.
    Kemeny N, Garay CA, Gurtler J, Hochster H, Kennedy P, Benson A, Brandt DS, Polikoff J, Wertheim M, Shumaker G, Hallman D, Burger B, Gupta S.
    J Clin Oncol; 2004 Dec 01; 22(23):4753-61. PubMed ID: 15570076
    [Abstract] [Full Text] [Related]

  • 10. [Clinical study of 5-Fluorouracil and l-Leucovorin therapy for 56 patients with advanced recurrent colorectal carcinoma].
    Matsuda T, Ogino K, Hiroyoshi M, Fujita H, Itoh T, Toyama H, Kawai Y, Makita D, Tsunemi K, Moritomo H, Nakamura T.
    Gan To Kagaku Ryoho; 2006 Jun 01; 33(6):783-7. PubMed ID: 16770097
    [Abstract] [Full Text] [Related]

  • 11. [Late phase II trial of high-dose l-leucovorin and 5-fluorouracil in advanced colorectal carcinoma. l-Leucovorin and 5-FU Study Group (Japan Eastern Group)].
    Yoshino M, Ota K, Kurihara M, Akazawa S, Tominaga T, Sasaki T, Konishi T, Kodaira S, Kumai K, Sugano K.
    Gan To Kagaku Ryoho; 1995 May 01; 22(6):785-92. PubMed ID: 7755386
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of advanced gastric and colorectal cancer with 5-FU, leucovorin and interferon-alpha].
    Tsujimura T, Ezaki K, Ono Y, Nakano H, Kawase K, Iwase K, Hatanaka T, Ohara K, Hobara R, Okamoto M.
    Gan To Kagaku Ryoho; 1993 Mar 01; 20(4):493-8. PubMed ID: 8452387
    [Abstract] [Full Text] [Related]

  • 13. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U, Wilke H, Seeber S.
    Semin Oncol; 1996 Oct 01; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [Abstract] [Full Text] [Related]

  • 14. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
    Garcia-Giralt E, Beuzeboc P, Deffontaines D, Diéras V, Dorval T, Jouve M, Palangie T, Scholl S, Pouillart P.
    J Infus Chemother; 1996 Oct 01; 6(3):149-51. PubMed ID: 9229328
    [Abstract] [Full Text] [Related]

  • 15. Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin as first-line therapy for patients with colorectal cancer.
    Hochster H, Chachoua A, Speyer J, Escalon J, Zeleniuch-Jacquotte A, Muggia F.
    J Clin Oncol; 2003 Jul 15; 21(14):2703-7. PubMed ID: 12860947
    [Abstract] [Full Text] [Related]

  • 16. A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.
    Yeh KH, Cheng AL, Lin MT, Hong RL, Hsu CH, Lin JF, Chang KJ, Lee PH, Chen YC.
    Anticancer Res; 1997 Jul 15; 17(5B):3867-71. PubMed ID: 9427794
    [Abstract] [Full Text] [Related]

  • 17. Bimonthly high dose leucovorin and 5-fluorouracil 48-hour continuous infusion in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).
    Beerblock K, Rinaldi Y, André T, Louvet C, Raymond E, Tournigand C, Carola E, Favre R, de Gramont A, Krulik M.
    Cancer; 1997 Mar 15; 79(6):1100-5. PubMed ID: 9070486
    [Abstract] [Full Text] [Related]

  • 18. High-dose infusional 5-fluorouracil combination therapy of metastatic gastric and colorectal cancer.
    Loeffler TM, Hausamen TU.
    J Infus Chemother; 1996 Mar 15; 6(3):137-40. PubMed ID: 9229325
    [Abstract] [Full Text] [Related]

  • 19. Palliative second-line treatment with weekly high-dose 5-fluorouracil as 24-hour infusion and folinic acid (AIO) plus oxaliplatin after pre-treatment with the AIO-regimen in colorectal cancer (CRC).
    Link K, Happich K, Schirner I, Jüngert B, Brückl V, Männlein G, Brückl WM, Merkel S, Göhl J, Hohenberger W, Hahn EG, Wein A.
    Anticancer Res; 2004 Mar 15; 24(1):385-91. PubMed ID: 15015625
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
    Yoshino T, Boku N, Onozawa Y, Hironaka S, Fukutomi A, Yamaguchi Y, Hasuike N, Yamazaki K, Machida N, Ono H.
    Jpn J Clin Oncol; 2007 Sep 15; 37(9):686-91. PubMed ID: 17720736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.